Who invested in Heart Metabolics?
Heart Metabolics's investors include AshHill Pharmaceutical Investments, EQT life science, venBio Partners, Seroba Kernel and Brandon Capital Partners.
United Kingdom · Series A startup
2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$24Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Heart Metabolics's investors include AshHill Pharmaceutical Investments, EQT life science, venBio Partners, Seroba Kernel and Brandon Capital Partners.
Heart Metabolics has raised $24M across 2 rounds since 2013.
Heart Metabolics's most recent round was a Series A of $20M in Apr 2014.
Its most recent round, $20M in Apr 2014, is also its largest on record.
Heart Metabolics's first round on record, in Jan 2013, was backed by AshHill Pharmaceutical Investments.
Heart Metabolics's latest named round is a Series A, in Apr 2014.
Heart Metabolics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.